Hepion Pharmaceuticals Inc (HEPA) stock is down -80.23% over the last 12 months, and the average rating from Wall Street analysts is a Hold. InvestorsObserver’s proprietary ranking system, gives HEPA stock a score of 12 out of a possible 100.
That rank is mainly influenced by a short-term technical score of 15. HEPA's rank also includes a long-term technical score of 21.
HEPA has an Overall Score of 12. Find out what this means to you and get the rest of the rankings on HEPA!
Hepion Pharmaceuticals Inc (HEPA) stock has risen 5.72% while the S&P 500 has gained 0.13% as of 9:56 AM on Friday, Mar 1. HEPA has gained $0.17 from the previous closing price of $2.97 on volume of 15,611 shares. Over the past year the S&P 500 has gained 28.17% while HEPA is down -80.23%. HEPA lost -$12.51 per share in the over the last 12 months.
Click Here to get the full Stock Report for Hepion Pharmaceuticals Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
